Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492944 · ClinicalTrials.gov registry record
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
A clinical trial of Crohn Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03492944: Active study of Crohn Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03492944 is a study of Crohn Disease that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 25 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03492944, a study of Crohn Disease, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease
Primary Outcome
Percent hyperenhancement (compared to normal bowel loops)
Conditions Studied
Interventions
- DEVICE Ultrasound Imaging
- DRUG Ultrasound Microbubble Contrast Agent
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2026-02 |
What the registry record for NCT03492944 still lists
NCT03492944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound Imaging is the first listed.
NCT03492944 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03492944 about?
NCT03492944 is a clinical study titled "Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason". The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease
What is the current status of trial NCT03492944?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2020-03-06. Estimated completion is 2026-02.
What conditions does trial NCT03492944 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT03492944?
The interventions under investigation include: Ultrasound Imaging (DEVICE), Ultrasound Microbubble Contrast Agent (DRUG).
Who is sponsoring clinical trial NCT03492944?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03492944 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03492944's enrollment target sits among peer trials
25 57th of 71 higher than 14 of 71 other Crohn Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Low Dose IL-2 for the Treatment of Crohn's Disease
RECRUITING · Phase 1
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI